Company Filing History:
Years Active: 2009-2014
Title: The Innovative Contributions of Peter Christopher Ray
Introduction
Peter Christopher Ray is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 3 patents, Ray's work focuses on developing compounds that have therapeutic applications.
Latest Patents
One of Ray's latest patents is for tricyclic heterocyclic derivatives. This invention relates to a tricyclic heterocyclic derivative according to a specific formula, which includes pharmaceutically acceptable salts or solvates. The invention is particularly relevant for treating serotonin-mediated disorders, such as obesity. Another significant patent involves 6-substituted isoquinoline derivatives. This patent describes compounds that can be used in pharmaceutical compositions for treating ROCK-I related disorders, including glaucoma, hypertension, and atherosclerosis.
Career Highlights
Throughout his career, Peter Christopher Ray has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with N.V. Organon and Merck Sharp & Dohme B.V. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Ray has collaborated with several professionals in his field, including Keneth Davies and Takao Kiyoi. These collaborations have likely enriched his research and development efforts, leading to impactful inventions.
Conclusion
Peter Christopher Ray's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex chemical compounds and their potential therapeutic uses.